about
Exploring cell tropism as a possible contributor to influenza infection severityThe in vivo efficacy of neuraminidase inhibitors cannot be determined from the decay rates of influenza viral titers observed in treated patientsHigh-resolution high-speed panoramic cardiac imaging system.Assessing mathematical models of influenza infections using features of the immune response.A fiber-based ratiometric optical cardiac mapping channel using a diffraction grating and split detector.Differences in predictions of ODE models of tumor growth: a cautionary example.Coinfections of the Respiratory Tract: Viral Competition for Resources.Assessing Uncertainty in A2 Respiratory Syncytial Virus Viral Dynamics.A comparison of methods for extracting influenza viral titer characteristics.The impact of cell regeneration on the dynamics of viral coinfection.Modelling the emergence of influenza drug resistance: The roles of surface proteins, the immune response and antiviral mechanisms.Determining drug efficacy parameters for mathematical models of influenza.Neuraminidase inhibitors for treatment of human and avian strain influenza: A comparative modeling study.Intermittent treatment of severe influenza.Quantifying rotavirus kinetics in the REH tumor cell line using in vitro data.A comparison of RSV and influenza in vitro kinetic parameters reveals differences in infecting time.Period-doubling bifurcation to alternans in paced cardiac tissue: crossover from smooth to border-collision characteristics.A quantitative assessment of dynamical differences of RSV infections in vitro and in vivoModeling of fusion inhibitor treatment of RSV in African green monkeysEffect of stochasticity on coinfection dynamics of respiratory virusesSpatial heterogeneity of restitution properties and the onset of alternansThe rate of viral transfer between upper and lower respiratory tracts determines RSV illness durationSuperinfection and cell regeneration can lead to chronic viral coinfectionsSARS-CoV-2 coinfections: Could influenza and the common cold be beneficial?
P50
Q28748187-99C77EBB-2297-41E9-9EB5-F92C9CBCBA6EQ30397216-744B423C-641A-4891-A8C6-DFC02C352820Q30483907-D8AC18F7-5EFD-447A-9ACF-EC1604F62CCCQ34611749-194056FB-95D8-4473-A8C0-88C05A99D59AQ35881236-D7047BDB-1422-4205-99CD-C856576338E6Q35938016-9E13CC91-5828-4633-A8E1-20807A66829DQ36022472-D9530C27-5BA7-4193-AC14-E969C9189F70Q38955037-F6B75125-F1A8-4634-9F4F-7B2B3440A7B1Q39994724-4606EAFE-F022-45F5-A102-C5FCF3B60622Q40134394-885A9A9F-00BC-4FC9-B986-182553DCB614Q40138039-8D685E45-986B-452D-9442-AB03A76CF09EQ41173978-FC6CEBF1-38AC-4269-9656-36FD59EA0086Q45104651-65778667-18D7-4531-972F-440F208A1AE3Q47550627-C0D13E52-DB3B-4A06-936F-204E18CB9876Q47588960-19BEE559-0C76-4599-8C73-8FB0C97765C3Q48506169-E4D169EC-2B1F-4BC8-832F-5A21A10F7D70Q55460469-97681519-015B-4576-B0B9-604AADB2CEEFQ59353915-EDF27058-1032-44FE-B6E5-122DF54F5B27Q59355948-FCEBC686-C9EA-47F3-A3DE-1EF275E1A69BQ64107187-FFB7C1D9-8CB9-457B-B1A9-AAE287B909E0Q84988257-3F78BFD8-8062-41EB-B44A-CE37880C24BEQ90219488-5C9BABD1-6C38-47E7-A8A8-8886665B2C97Q91030780-511C5521-8DA2-4C21-B879-7545BFB03E0CQ96584752-519099BB-5896-4125-998C-46CE3BA6DBBF
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-3592-6770
@en
name
Hana M Dobrovolny
@ast
Hana M Dobrovolny
@en
Hana M Dobrovolny
@es
Hana M Dobrovolny
@nl
type
label
Hana M Dobrovolny
@ast
Hana M Dobrovolny
@en
Hana M Dobrovolny
@es
Hana M Dobrovolny
@nl
prefLabel
Hana M Dobrovolny
@ast
Hana M Dobrovolny
@en
Hana M Dobrovolny
@es
Hana M Dobrovolny
@nl
P108
P106
P1153
6506587322
P21
P31
P496
0000-0003-3592-6770